Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

442 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Disease steps in multiple sclerosis: a simple approach to evaluate disease progression.
Hohol MJ, Orav EJ, Weiner HL. Hohol MJ, et al. Among authors: orav ej. Neurology. 1995 Feb;45(2):251-5. doi: 10.1212/wnl.45.2.251. Neurology. 1995. PMID: 7854521
Negligent care and malpractice claiming behavior in Utah and Colorado.
Studdert DM, Thomas EJ, Burstin HR, Zbar BI, Orav EJ, Brennan TA. Studdert DM, et al. Among authors: orav ej. Med Care. 2000 Mar;38(3):250-60. doi: 10.1097/00005650-200003000-00002. Med Care. 2000. PMID: 10718350
Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.
Sperling RA, Guttmann CR, Hohol MJ, Warfield SK, Jakab M, Parente M, Diamond EL, Daffner KR, Olek MJ, Orav EJ, Kikinis R, Jolesz FA, Weiner HL. Sperling RA, et al. Among authors: orav ej. Arch Neurol. 2001 Jan;58(1):115-21. doi: 10.1001/archneur.58.1.115. Arch Neurol. 2001. PMID: 11176944
Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
Hohol MJ, Orav EJ, Weiner HL. Hohol MJ, et al. Among authors: orav ej. Mult Scler. 1999 Oct;5(5):349-54. doi: 10.1177/135245859900500508. Mult Scler. 1999. PMID: 10516779
Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.
Hohol MJ, Khoury SJ, Cook SL, Orav EJ, Hafler DA, Weiner HL. Hohol MJ, et al. Among authors: orav ej. Ann N Y Acad Sci. 1996 Feb 13;778:243-50. doi: 10.1111/j.1749-6632.1996.tb21132.x. Ann N Y Acad Sci. 1996. PMID: 8610977 Clinical Trial. No abstract available.
Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis.
Khoury SJ, Guttmann CR, Orav EJ, Kikinis R, Jolesz FA, Weiner HL. Khoury SJ, et al. Among authors: orav ej. Arch Neurol. 2000 Aug;57(8):1183-9. doi: 10.1001/archneur.57.8.1183. Arch Neurol. 2000. PMID: 10927799
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
Khoury SJ, Orav EJ, Guttmann CR, Kikinis R, Jolesz FA, Weiner HL. Khoury SJ, et al. Among authors: orav ej. Neurology. 1999 Sep 11;53(4):758-64. doi: 10.1212/wnl.53.4.758. Neurology. 1999. PMID: 10489037
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL. Hohol MJ, et al. Among authors: orav ej. Mult Scler. 1999 Dec;5(6):403-9. doi: 10.1177/135245859900500i606. Mult Scler. 1999. PMID: 10618696
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.
Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA. Weiner HL, et al. Among authors: orav ej. Science. 1993 Feb 26;259(5099):1321-4. doi: 10.1126/science.7680493. Science. 1993. PMID: 7680493 Clinical Trial.
Prediction of visual function after cataract surgery. A prospectively validated model.
Mangione CM, Orav EJ, Lawrence MG, Phillips RS, Seddon JM, Goldman L. Mangione CM, et al. Among authors: orav ej. Arch Ophthalmol. 1995 Oct;113(10):1305-11. doi: 10.1001/archopht.1995.01100100093037. Arch Ophthalmol. 1995. PMID: 7575265
442 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback